Latanoprost Tris(triethylsilyl) Ether
96%
- Product Code: 201630
CAS:
477884-78-9
| Molecular Weight: | 775.38 g./mol | Molecular Formula: | C₄₄H₈₂O₅Si₃ |
|---|---|---|---|
| EC Number: | MDL Number: | MFCD28579796 | |
| Melting Point: | Boiling Point: | ||
| Density: | Storage Condition: | Room temperature |
Product Description:
Used in the synthesis of latanoprost, a key ophthalmic medication for treating glaucoma and ocular hypertension. Acts as a protected intermediate during manufacturing, where the tris(triethylsilyl) ether groups shield reactive sites on the molecule, ensuring selective chemical transformations. This protection improves yield and purity in the final active pharmaceutical ingredient. Commonly employed in multi-step organic synthesis under controlled conditions to enable precise functional group manipulation.
Sizes / Availability / Pricing:
| Size | Availability | Price | Quantity |
|---|---|---|---|
| 25mg | 10-20 days | $11,743.47 |
+
-
|
Latanoprost Tris(triethylsilyl) Ether
Used in the synthesis of latanoprost, a key ophthalmic medication for treating glaucoma and ocular hypertension. Acts as a protected intermediate during manufacturing, where the tris(triethylsilyl) ether groups shield reactive sites on the molecule, ensuring selective chemical transformations. This protection improves yield and purity in the final active pharmaceutical ingredient. Commonly employed in multi-step organic synthesis under controlled conditions to enable precise functional group manipulation.
| Mechanism | - |
| Appearance | - |
| Longevity | - |
| Strength | - |
| Storage | - |
| Shelf Life | - |
| Allergen(s) | - |
| Dosage (Range) | - |
| Recommended Dosage | - |
| Dosage (Per Day) | - |
| Recommended Dosage (Per Day) | - |
| Mix Method | - |
| Heat Resistance | - |
| Stable in pH range | - |
| Solubility | - |
| Product Types | - |
| INCI | - |
Purchase History for
Loading purchase history...
Cart
No products
Subtotal:
$0.00
$0.00
Total :